tase inhibitor, affects primarily the tissues that are growing most rapidly. When in prolonged contact with the cell, its interference with the supply ,of available folic acid reduces the DNH content and hence holds up preparation for mitosis and division. Apart from neoplastic cells, the rapid epidermal proliferation of psoriasis is particularly susceptible; after this the brunt of the attack falls on the endothelium of the oral mucosa and gastro-intestinal tract, the hair follicles, and later the blood-forming elements-especially the granulocytes. The drug is easily absorbed orally and the greater part is excreted in the urine within 12 hours. Impaired renal function potentiates its effect, pregnancy is a contraindication, and over-dosage should be treated with folinic acid (Leucovorin) .
Folic acid antagonists were first used in the treatment of psoriasis by Gubner, August, and Ginsberg (1951) . Further reports on their use in this disease were made by Rees, Bennett, Hamlin, and Maibach (1964) , and Ryan, Vickers, Salem, Callender, and Badenoch (1964) , three deaths being reported by the former. Shrank and Blendis (1965) Recently Haim, and Alroy (1967) reported deaths after 5 and 7 days respectively of 5 0 mg. methotrexate, plus steroids, apparently from leucopenia and sepsis. Burrows and Kelly (1967) recorded severe toxicity and leucopenia with recovery in 3 weeks after taking only 2 * 5 mg. for 4 days.
Present Investigations A case of severe pustular psoriatic arthritis reacted so well to methotrexate, relapsing when the drug was stopped and improving again when it was restarted, that further investigation of its effect both on the psoriasis and arthritis was prompted.
Case Report
A man aged 52 years noticed stiffness after exercise at the age of 30 and had an attack of bilateral sciatica at age 37. In March, 1964, at the age of 48, he developed simultaneously severe psoriasis and arthritis of the right elbow and left shoulder.
When seen in August, 1964, he had a very severe generalized psoriasis, pustular psoriasis of the fingernails and toenails, and extremely swollen and partly subluxated knees and ankles. The neck and back were stiff but there was little pain. He had lost a stone in weight and his temperature rose to 1010 F. at night. The erythrocyte sedimentation rate was 120 mm./hr., Hb 70 per cent., and rheumatoid factor tests negative.
He was immediately given ACTH 40 units daily, erythromycin, and imferon injections. The results were most disappointing, the haemoglobin dropping to 60 per cent. The white count was 5,000/cu. mm. with 78 per cent. polymorphs. He was transfused with packed red cells, and prednisolone rising to 15 mg./day was added, yet by November he was extremely ill. He was then given 4 mg. betamethasone (Betnesol), equivalent to approximately 35 mg. prednisolone, plus 2-5 mg. methotrexate on 5 days per week, and the ACTH was stopped. Improvement was dramatic and the medication was continued for 7 months, with very gradual reduction of the betamethasone to 2 mg., until June, 1965.
The patient was now a changed man. The erythrocyte sedimentation rate had fallen from 80 to 2 mm./hr., the Hb was 104 per cent., and the white cell count had changed from 8,800 to 6,400/cu. mm. He had, however, gained too much weight and was walking with sticks. The psoriasis was well controlled and all infection had disappeared. The only trouble during the period had been a collapsed vertebra in February, 1965, which Estos resultados muestran que la frecuencia de reacciones t6xicas y la duraci6n probable de la regresion sintomAtica son tales que este producto no se puede aconsejar para un tratamiento regular. Sin embargo, ciertos enfermos le toleran bien y en casos graves y cuidadosamente escogidos su empleo pueder ser util.
La experiencia de Burrows y Kelly (1967) y la de Haim y Alroy (1967) y los resultados obtenidos con dos enfermos nuestros (casos 10 y 11) sugieren que algunos sujetos son particularmente sensibles a Methotrerate; otros, sin embargo, lo aguantan muy bien y a veces durante un tratamiento prolongado (casos 1 y 9). 
